BioSpace News Archive

Business

Agenus First Quarter 2020 Results and Update

Agenus Inc., an immuno-oncology company with an extensive pipeline of agents designed to activate immune response to cancers provided a corporate update and reported financial results for the first quarter of 2020.

May 7, 2020
·
6 min read
Deals

Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - May 07, 2020

Insmed Incorporated, a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, announced the granting of inducement awards to 11 new employees.

May 7, 2020
·
2 min read
Policy

Camber Spine Technologies Announces Nationwide Launch Of SPIRA®-C Integrated And FORTICO Anterior Cervical Plate

C Integrated, surgeons now have a zero profile, screw fixated interbody option for anterior cervical fusions with all the benefits of the SPIRA®- open architecture design.

May 7, 2020
·
2 min read
BioCapital

PARI Nebulizer Used in New Study with Pulmotect’s Inhaled PUL-042 for COVID-19

This week, the first patients are enrolling in two phase 2 clinical trials for COVID-19 using Pulmotect’s PUL-042, an inhaled immunomodulatory agent to prevent and treat coronavirus infections, delivered by PARI’s LC Sprint Reusable Nebulizer.

May 7, 2020
·
2 min read
Biotech Bay

Sight Sciences Introduces the Next-Generation OMNI® Surgical System for Microinvasive Glaucoma Surgery

Enhanced Design Offers Improved Ergonomics and Procedural Efficiency for the Only Device that Targets the Three Points of Resistance in the Conventional Outflow Pathway

May 7, 2020
·
4 min read
Policy

Arcadia Biosciences Significantly Expands Intellectual Property Portfolio with Four U.S. Patents

Patents further protect company’s GoodWheat™ specialty wheat ingredients

May 7, 2020
·
4 min read
BioForest

Sierra Oncology to Hold KOL Call to Discuss Anemia & Transfusion Dependency as Critical Unmet Needs in Myelofibrosis

Event featuring renowned myelofibrosis expert Dr. Ruben Mesa scheduled for 10:00 am ET on Wednesday, May 13th

May 7, 2020
·
5 min read
Biotech Beach

Halozyme To Present At The Bank Of America Securities 2020 Healthcare Conference

Halozyme Therapeutics, Inc., will participate in the Bank of America Securities 2020 Healthcare Conference.

May 7, 2020
·
1 min read
Biotech Beach

Genelux Corporation Announces Productive Type C Meeting with FDA

Genelux Corporation, a privately-held, clinical-stage immunotherapy company, today announced the outcome of a Type C meeting with the U.S. Food and Drug Administration (FDA) held on M

May 7, 2020
·
2 min read
Policy

Daiichi Sankyo Submits Supplemental New Drug Application for Trastuzumab Deruxtecan in Japan for Treatment of Patients with HER2 Positive Metastatic Gastric Cancer

Trastuzumab deruxtecan to receive expedited review by Japan MHLW based on SAKIGAKE designation for second potential indication in Japan

May 7, 2020
·
16 min read